3UON
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 23-ID-D |
| Synchrotron site | APS |
| Beamline | 23-ID-D |
| Temperature [K] | 78 |
| Detector technology | CCD |
| Collection date | 2011-02-10 |
| Detector | MARMOSAIC 300 mm CCD |
| Wavelength(s) | 1.033 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 78.170, 47.260, 88.120 |
| Unit cell angles | 90.00, 109.70, 90.00 |
Refinement procedure
| Resolution | 27.466 - 3.000 |
| R-factor | 0.2274 |
| Rwork | 0.225 |
| R-free | 0.27640 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | Beta2 adrenergic receptor T4 lysozyme (PDB ENTRY 2RH1) |
| RMSD bond length | 0.002 |
| RMSD bond angle | 0.573 |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX ((phenix.refine: 1.7.1_743)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 27.500 | 3.050 |
| High resolution limit [Å] | 3.000 | 3.000 |
| Rmerge | 0.185 | 0.454 |
| Number of reflections | 11726 | |
| <I/σ(I)> | 6.1 | 1.4 |
| Completeness [%] | 94.1 | 79.2 |
| Redundancy | 3.5 | 2.4 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | 7.5 | 293 | 25 to 35% PEG 300, 100 mM ammonium phosphate, 2% 2-Methyl-2,4-pentanediol, 100 mM HEPES, 10:1 monoolein:cholesterol lipid mix diluted 1.5:1 with protein in detergent buffer, Lipidic cubic phase, temperature 293K, pH 7.5 | |
| 1 | 7.5 | 293 | 25 to 35% PEG 300, 100 mM ammonium phosphate, 2% 2-Methyl-2,4-pentanediol, 100 mM HEPES, 10:1 monoolein:cholesterol lipid mix diluted 1.5:1 with protein in detergent buffer, Lipidic cubic phase, temperature 293K, pH 7.5 |






